Physician profile
Edward W Lambert
NPI 1194786640
$20,319.60
in general payments reported to CMS, 2019-2025
20 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,862 · 2020: $2,614 · 2021: $3,044 · 2022: $1,821 · 2023: $2,051 · 2024: $190 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,700 · Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,700.00 |
| Food and Beverage | $1,278.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $15,672.27 | 2019-2025 | Actis, Pinnacle, Attune |
| Depuy Synthes Sales INC. | $2,574.18 | 2019-2025 | Velys, Attune, Kincise |
| Zimmer Biomet Holdings, INC. | $1,016.60 | 2019-2023 | Rosa, Zimmer Collagen Patch |
| Stryker Corporation | $297.20 | 2019-2025 | Insignia, Mako, Tritanium |
| Bioventus LLC | $212.91 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane, Xcell |
| Abbott Laboratories | $86.58 | 2021-2025 | Proclaim |
| Ferring Pharmaceuticals INC. | $57.76 | 2019-2022 | |
| Smith+Nephew, INC. | $57.73 | 2019 | |
| Lifenet Health | $49.74 | 2025 | Theragenesis Wound Matrix |
| Davol INC. | $42.85 | 2023 | Arista Ah Flexitip |
| Dynasplint Systems INC. | $37.85 | 2023-2025 | Dynasplint |
| Si-Bone, INC. | $33.86 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.13 | 2025 | |
| Avanos Medical | $28.71 | 2022-2023 | On-Q* Pump and Accessories |
| Endo USA, INC. | $21.84 | 2025 | Xiaflex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $20.29 | 2024 | Tymlos |
| Pacira Therapeutics, INC. | $19.55 | 2019 | |
| Molnlycke Health Care US, LLC | $19.54 | 2023 | Mepilex Border Post-Op Ag |
| Heron Therapeutics, INC. | $18.77 | 2021 | |
| Fidia Pharma USA INC. | $18.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.